INSTITUTE OF LIFE SCIENCES
Bhubaneswar 751023
Advt. No. 30/2017
Institute of Life Sciences (ILS), Bhubaneswar, an autonomous institute of the
Department of Biotechnology, Ministry of Science & Technology, Government of India invites
applications from Indian Nationals to join in the following position.
Name of position: Research Associate, Molecular Virology (01 No)
Fellowship: Rs. 36000/- per month + @20% HRA
Eligibility and Selection: Ph. D. in Biotechnology/Life Sciences or allied subjects. The ideal
candidate has to be competent in Viral infection, animal handling, cell culture, Flow
Cytometric Analysis, Viral plaque assay, RT-PCR etc.
A decent publication record from Ph.D.
work is also expected.
Candidates who have submitted Ph.D. thesis and are waiting for viva
voce may also apply. For such candidates, fellowship amount will be that of an SRF until
he/she defends Ph.D. thesis.
Selection will be carried out through application screening,
followed by an interview process.
Interested/eligible candidates may download application form from the institute website
(www.ils.res.in ) and apply along with self-attested copies of mark sheets and certificates,
as well as copies of publications and Ph. D. thesis synopsis to The Director, Institute of
Life Sciences, Nalco Square, Bhubaneswar-751023. Super scribe the envelope with
"Application for the position of Research Associate–Molecular Virology". Initial
appointment will be for one year.
No TA/DA will be paid for attending the interview. The
decision of the institute Director regarding selection of candidates will be final and no further
correspondence will be entertained in this regard. The names of the shortlisted candidates
will be displayed in the ILS webpage with the date and time of interview.
1. Last date for receiving application: 10/January/2018
2. Date of display of shortlisted candidates: 11/January/2018
3. Date & time of interview: 18/January/2018; 10.30 AM
Note: All communication will be through e-mail. No separate call letter will
be issued to the candidates.
0 Comments